CN Patent
CN103360391A — 阿哌沙班新晶型及其制备方法
Assigned to QILU PHARMACEUTICAL (HAINAN) CO Ltd · Expires 2013-10-23 · 13y expired
What this patent protects
本发明属于医药化工技术领域,具体涉及一种阿哌沙班的新的晶型β,并公开了制备该晶体形式的方法,该方法工艺简单,操作方便,条件温和,不需要特殊的反应条件,因此更适合工业化生产。
USPTO Abstract
本发明属于医药化工技术领域,具体涉及一种阿哌沙班的新的晶型β,并公开了制备该晶体形式的方法,该方法工艺简单,操作方便,条件温和,不需要特殊的反应条件,因此更适合工业化生产。
Drugs covered by this patent
- Eliquis (apixaban) · Bristol-Myers Squibb
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.